These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1414477)

  • 1. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
    J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia.
    Seikaly MG; Browne RH; Baum M
    Pediatrics; 1994 Oct; 94(4 Pt 1):478-81. PubMed ID: 7936855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U; Chan JC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
    Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
    J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypophosphatemic rickets: still misdiagnosed and inadequately treated.
    Greene WB; Kahler SG
    South Med J; 1985 Oct; 78(10):1179-84. PubMed ID: 2996152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic advances, biochemical and clinical features and critical approach to treatment of patients with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Sodini F; Galli L; Vanacore T; Fiore L; Saggese G
    Pediatr Endocrinol Rev; 2004 Jun; 1(4):361-79. PubMed ID: 16437029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early diagnosis and early treatment of hypophosphatemic vitamin D-resistant rickets].
    Schaumberger E; Hohenauer L; Sommer R
    Klin Padiatr; 1986; 198(1):44-8. PubMed ID: 3007858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Saggese G
    J Pediatr; 2001 Feb; 138(2):236-43. PubMed ID: 11174622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L
    J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Jones G
    J Clin Invest; 1990 May; 85(5):1450-5. PubMed ID: 2332500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG; Brown R; Baum M
    Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults.
    Reid IR; Hardy DC; Murphy WA; Teitelbaum SL; Bergfeld MA; Whyte MP
    Medicine (Baltimore); 1989 Nov; 68(6):336-52. PubMed ID: 2811660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization.
    Costa T; Marie PJ; Scriver CR; Cole DE; Reade TM; Nogrady B; Glorieux FH; Delvin EE
    J Clin Endocrinol Metab; 1981 Mar; 52(3):463-72. PubMed ID: 6893992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
    Scriver CR; Reade TM; DeLuca HF; Hamstra AJ
    N Engl J Med; 1978 Nov; 299(18):976-9. PubMed ID: 308618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
    Seikaly MG; Quigley R; Baum M
    Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial hypophosphatemic rickets. Effects of treatment with 1,25-dihydroxycholecalciferol at supraphysiologic doses].
    Saggese G; Baroncelli GI; Bertelloni S; Federico G
    Minerva Pediatr; 1987 May; 39(10):451-5. PubMed ID: 3657736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.